1.8(top 50%)
impact factor
1.6K(top 10%)
papers
24.1K(top 10%)
citations
59(top 10%)
h-index
2.0(top 20%)
impact factor
2.0K
all documents
25.9K
doc citations
92(top 10%)
g-index

Top Articles

#TitleJournalYearCitations
1Intracellular coenzymes as natural biomarkers for metabolic activities and mitochondrial anomaliesBiomarkers in Medicine2010383
2Exosomes: the future of biomarkers in medicineBiomarkers in Medicine2013342
3Current developments in salivary diagnosticsBiomarkers in Medicine2010304
4Recommendations to standardize preanalytical confounding factors in Alzheimer’s and Parkinson’s disease cerebrospinal fluid biomarkers: an updateBiomarkers in Medicine2012280
5Neutrophil gelatinase-associated lipocalin: a  promising biomarker for human acute kidney injuryBiomarkers in Medicine2010275
6Early diagnosis of pancreatic cancer: challenges and new developmentsBiomarkers in Medicine2012201
7Biomarkers of oxidative damage and inflammation in Alzheimer’s diseaseBiomarkers in Medicine2010191
8Brain inflammation as a biomarker in epilepsyBiomarkers in Medicine2011182
9Stability of miRNA in human urine supports its biomarker potentialBiomarkers in Medicine2013173
10CA125 in ovarian cancerBiomarkers in Medicine2007164
11Blood-based biomarkers of Alzheimer’s disease: challenging but feasibleBiomarkers in Medicine2010162
12Oxidized phospholipids on apoB-100-containing lipoproteins: a biomarker predicting cardiovascular disease and cardiovascular eventsBiomarkers in Medicine2011156
13Alzheimer’s Prevention Initiative: a proposal to evaluate presymptomatic treatments as quickly as possibleBiomarkers in Medicine2010150
14Correlating familial Alzheimer’s disease gene mutations with clinical phenotypeBiomarkers in Medicine2010145
15From pharmacogenomic knowledge acquisition to clinical applications: the PharmGKB as a clinical pharmacogenomic biomarker resourceBiomarkers in Medicine2011145
16High-frequency oscillations and other electrophysiological biomarkers of epilepsy: clinical studiesBiomarkers in Medicine2011144
17γ-band abnormalities as markers of autism spectrum disordersBiomarkers in Medicine2014141
18Circulating levels of brain-derived neurotrophic factor: correlation with mood, cognition and motor functionBiomarkers in Medicine2010137
19Neuroimaging in amyotrophic lateral sclerosisBiomarkers in Medicine2012133
20Toward predictive models for drug-induced liver injury in humans: are we there yet?Biomarkers in Medicine2014124
21hsa_circRNA_103636: potential novel diagnostic and therapeutic biomarker in Major depressive disorderBiomarkers in Medicine2016119
22Urate: a novel biomarker of Parkinson’s disease risk, diagnosis and prognosisBiomarkers in Medicine2010117
23Quantification of α-synuclein in cerebrospinal fluid as a biomarker candidate: review of the literature and considerations for future studiesBiomarkers in Medicine2010113
24Integration and use of biomarkers in drug development, regulation and clinical practice: a US regulatory perspectiveBiomarkers in Medicine2008107
25Molecular biomarkers in stroke diagnosis and prognosisBiomarkers in Medicine2009105
26The biology of glucagon and the consequences of hyperglucagonemiaBiomarkers in Medicine2016102
27Endothelial function as a functional expression of cardiovascular risk factorsBiomarkers in Medicine2010100
28Upcoming candidate cerebrospinal fluid biomarkers of Alzheimer’s diseaseBiomarkers in Medicine2012100
29Cancer stem cells in triple-negative breast cancer: a potential target and prognostic markerBiomarkers in Medicine201895
30Metabolic pathology of autism in relation to redox metabolismBiomarkers in Medicine201493
31Lung cancer epigenetics: emerging biomarkersBiomarkers in Medicine201389
32Next-generation, genome sequencing-based biomarkers: concerns and challenges for medical practiceBiomarkers in Medicine201086
33The utility of α-synuclein as biofluid marker in neurodegenerative diseases: a systematic review of the literatureBiomarkers in Medicine201686
34Circulating microparticles reflect treatment effects and clinical status in multiple sclerosisBiomarkers in Medicine201484
35Tau as a biomarker of neurodegenerative diseasesBiomarkers in Medicine200883
36Comprehensive next-generation cancer genome sequencing in the era of targeted therapy and personalized oncologyBiomarkers in Medicine201183
37Redefining the endophenotype concept to accommodate transdiagnostic vulnerabilities and etiological complexityBiomarkers in Medicine201783
38Methods of rapid diagnosis for the etiology of meningitis in adultsBiomarkers in Medicine201481
39Future of liquid chromatography–mass spectrometry in metabolic profiling and metabolomic studies for biomarker discoveryBiomarkers in Medicine200778
40Role of hematological parameters in COVID-19 patients in the emergency roomBiomarkers in Medicine202078
41Reference measurement procedures for Alzheimer’s disease cerebrospinal fluid biomarkers: definitions and approaches with focus on amyloid β42Biomarkers in Medicine201276
42Early detection of ovarian cancerBiomarkers in Medicine200874
43Aspects of β-amyloid as a biomarker for Alzheimer’s diseaseBiomarkers in Medicine200773
44Biomarkers in systemic sclerosisBiomarkers in Medicine201072
45Circulating microRNAs: potential biomarkers for common malignanciesBiomarkers in Medicine201572
46Oxidative stress in ischemia and reperfusion: current concepts, novel ideas and future perspectivesBiomarkers in Medicine201771
47Downregulated expression of hsa_circ_0074362 in gastric cancer and its potential diagnostic valuesBiomarkers in Medicine201871
48Systemic immune-inflammation index is a novel marker to predict functionally significant coronary artery stenosisBiomarkers in Medicine202071
49Lipidomics applications for disease biomarker discovery in mammal modelsBiomarkers in Medicine201570
50Monocyte/HDL-cholesterol ratio predicts the definite stent thrombosis after primary percutaneous coronary intervention for ST-segment elevation myocardial infarctionBiomarkers in Medicine201570